Over 30 members attended the seminar on-site, and 50 joined virtually.
In this seminar, representatives from Linklaters will cover key enforcement trends in the past year, as well as provide you with insights into proceedings in the Competition Tribunal. We will also discuss how this is relevant to the pharmaceutical industry in Hong Kong and practical tips to ensure full compliance with competition law.
The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.
Dear member, Mr Da LIU, the author of “Lessons for Investment in Biotech Companies”, will share his insight of investing in Biotech companies to HKAPI members on February 17, 2022. […]
Dear member, At the beginning of the year of Tiger, the HKAPI organizes an intensive class on Thrive with Energy Programme for improving the personal well-being of members. With the […]
Topic: Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong Speaker: Dr. Daniel Lee, Associate Vice-President (Innovation and Enterprise), The Chinese University of Hong Kong Language: English Target […]
GBA Sharing Session: Experience of importing HK-registered drugs and medical devices in GBA; Expectation and Preparation of the expanded phase
[Speakers and Language updated] Webinar topics and speakers: The newly announced designated healthcare institution: preparation and expectation in importing HK-registered drugs and medical devices to the GBA – Dr. Michael […]
Dear Member, Blockchain is a new technology applied in different industry and we have heard a lot. This is an opportunity that Blockchain Solution Ltd Joined HKAPI as a member […]
Digitalization impact every corner of society and every walk of life in particular under the Covid pandemic. Meanwhile, health literacy is another global issue. Adoption and adherence to treatment options […]